Hatori Kouki, Sasano Yasuyuki, Takahashi Ichiro, Kamakura Shinji, Kagayama Manabu, Sasaki Keiichi
Division of Advanced Prosthetic Dentistry, Tohoku University Graduate School of Dentistry, Sendai, Japan.
Anat Rec A Discov Mol Cell Evol Biol. 2004 Apr;277(2):262-71. doi: 10.1002/ar.a.20007.
Our previous studies suggested that a part of bone extracellular matrix (ECM) molecules are degraded and remodeled during embryonic bone formation. In contrast, little is known about ECM remodeling in postnatal appositional bone formation. The present study was designed to investigate expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) during experimentally initiated appositional bone formation in rats. Expressions of ECM molecules, MMPs, and TIMPs were examined using in situ hybridization. Osteoblasts and osteocytes expressed MMP2 and -8, TIMP1, -2, and -3, as well as type I collagen, osteopontin, and osteocalcin in the course of the appositional bone formation, while they showed few transcripts of MMP13. The results indicated that while osteoblasts and osteocytes in the apposed bone produce ECM molecules, they degrade ECM molecules with MMPs and regulate the degradation by inhibiting the activity of MMPs using TIMPs. Osteoblasts and osteocytes may reorganize the ECM composition to mature the bone matrix in appositional bone formation.
我们之前的研究表明,在胚胎期骨形成过程中,一部分骨细胞外基质(ECM)分子会被降解和重塑。相比之下,关于出生后骨沉积性骨形成过程中的ECM重塑却知之甚少。本研究旨在探讨实验性诱导大鼠骨沉积性骨形成过程中基质金属蛋白酶(MMPs)和金属蛋白酶组织抑制剂(TIMPs)的表达情况。使用原位杂交技术检测ECM分子、MMPs和TIMPs的表达。在骨沉积性骨形成过程中,成骨细胞和骨细胞表达MMP2和-8、TIMP1、-2和-3,以及I型胶原蛋白、骨桥蛋白和骨钙素,而它们几乎没有MMP13的转录本。结果表明,在骨沉积中,成骨细胞和骨细胞在产生ECM分子的同时,会用MMPs降解ECM分子,并通过使用TIMPs抑制MMPs的活性来调节降解过程。成骨细胞和骨细胞可能会重组ECM成分,以使骨沉积性骨形成中的骨基质成熟。